Britannia Life Sciences Inc. (BLSIF)

OTCMKTS · Delayed Price · Currency is USD

0.0600

0.00 (0.00%)

Aug 31, 2026, 4:00 PM EST

-23.08% (1Y)

Market Cap	8.32M +0.9%
Revenue (ttm)	286.20K +6.0%
Net Income	11.65M +122.3%
EPS	0.07 +122.1%
Shares Out	n/a
PE Ratio	0.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0600
Previous Close	0.0600
Day's Range	0.0600 - 0.0600
52-Week Range	0.0300 - 0.0780
Beta	-0.07
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2026

About Britannia Life Sciences

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. The company serves cosmetics, consumer packaged and household goods, and nutraceutical industries. Britannia Life Sciences Inc. is headquartered in Toronto, Canada. [Read more]

Industry Biotechnology

Sector Healthcare

CEO Peter Shippen

Country Canada

Stock Exchange OTCMKTS

Ticker Symbol BLSIF

Financial Performance

In fiscal year 2026, Britannia Life Sciences's revenue was 474,834, an increase of 28.58% compared to the previous year's 369,279. Earnings were 14.65 million, an increase of 98.18%.

Financial numbers in CAD Financial Statements